Gene Editing Market to Grow with a CAGR of 8.98% through 2029
Continuous advancements in gene editing technologies are expected to drive the Global Gene Editing Market growth in the forecast period, 2025-2029.
According to TechSci Research report,
“Gene Editing Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029F”, the Global
Gene Editing Market stood at USD 5.79 Billion in 2023
and is anticipated to grow with a CAGR of 8.98% through 2029. The Global Gene Editing Market is undergoing significant growth, primarily fueled by the expanding use of gene editing technologies within the healthcare sector. A key driver of this expansion is the notable advancements in utilizing gene editing tools like CRISPR-Cas9 to create cutting-edge therapies for genetic disorders. Researchers can now precisely target and modify disease-causing genes, presenting new avenues for treating previously untreatable genetic conditions. The concept of personalized medicine is swiftly transitioning into reality, with gene editing enabling tailored interventions that address the unique genetic profiles of individual patients.
Within the realm of healthcare applications, cancer treatment has emerged as a focal area for gene editing. This technology is being employed to refine the precision of cancer therapies by altering genes associated with tumor growth and resistance to treatment. Gene editing is also pivotal in the development of immunotherapies, where genetic modifications of immune cells bolster their ability to recognize and eliminate cancer cells. These advancements not only enhance the effectiveness of cancer treatments but also contribute to the evolution of more personalized and precisely targeted therapeutic strategies.
Browse over XX Market data Figures
spread through XX Pages and an in-depth TOC on "Global Gene Editing Market”
The Global Gene Editing Market is segmented into product & service, technology, application, end
user, regional distribution, and company.
Based on End User, Biotech have emerged as the dominating Global Gene Editing Market in 2023. Biotech firms specialize in pioneering technologies and treatments, including gene editing. They typically employ dedicated teams of scientists and researchers proficient in molecular biology, genetics, and bioengineering, facilitating ongoing innovation and progression in gene editing methodologies. These companies secure substantial investment and funding from various sources such as venture capital firms, government grants, and private investors. This financial backing empowers them to conduct extensive research and development efforts, expedite product advancement, and introduce groundbreaking gene editing therapies to the market. Biotech enterprises primarily concentrate on crafting gene editing therapies tailored to address genetic disorders, cancers, and other ailments. Their focus on therapeutic applications fosters ongoing innovation and investment in medical-grade gene editing technology, positioning them as leaders in the market. The escalating demand for gene editing technologies and treatments, fueled by the rising incidence of genetic disorders, cancers, and other medical conditions, presents lucrative opportunities for biotech companies. Leveraging their commitment to developing inventive solutions that meet unmet medical needs, biotech firms are poised to dominate the global gene editing market.
Based on Region, Europe have emerged as the fastest growing region in the Global Gene Editing Market during the forecast period. Europe hosts prestigious research institutions, universities, and biotech firms leading the way in gene editing research. These entities foster collaboration and innovation, propelling advancements in gene editing technologies and therapies. Additionally, Europe boasts a robust regulatory framework for biotechnology and gene editing, overseen by the European Medicines Agency (EMA). The EMA ensures the approval process for gene therapy products adheres to stringent safety, efficacy, and ethical standards, instilling confidence in investors and facilitating the transition of research into commercial applications. Furthermore, Europe demonstrates a strong commitment to tackling rare diseases and promoting personalized medicine. European biotech companies actively pursue therapies for rare genetic disorders, leveraging the potential of gene editing technologies. Moreover, Europe places significant emphasis on ethical considerations and public engagement in scientific endeavors. This supportive stance toward responsible gene editing research and its potential benefits fosters an environment conducive to growth in the gene editing market.
Major companies operating in Global Gene
Editing Market are:
·
CRISPR Therapeutics AG
·
Merck KGaA
·
Thermo Fisher Scientific, Inc.
·
GenScript Biotech Corporation
·
Agilent Technologies, Inc.
·
PerkinElmer Inc.
·
Lonza Group Ltd.
·
Tecan Trading AG
·
Sangamo Therapeutics, Inc.
·
Editas Medicine, Inc.
Download Free Sample Report
Customers can also request for 10% free
customization on this report
“The Global Gene Editing market is being driven by a growing need for advanced genetic manipulation tools, with CRISPR-Cas9 emerging as a frontrunner. The escalating prevalence of genetic disorders, combined with the expanding capabilities of gene editing technologies, has spurred significant investment and collaboration within the healthcare sector. Pharmaceutical firms, biotech startups, and research institutions are actively investigating the therapeutic potential of gene editing, resulting in a robust pipeline of gene-based therapies at various developmental stages. The biotech sector is exploring a diverse range of applications for gene editing, spanning agriculture, biofuels, and industrial biotechnology, in addition to healthcare. This broadening of applications creates fresh revenue streams and market prospects, driving rapid market expansion. Regulatory bodies are increasingly acknowledging the potential of gene editing and are establishing pathways to expedite the approval of gene-editing-based therapies. This regulatory backing is vital for biotech enterprises to expedite the commercialization of their innovative products”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Gene Editing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Reagents & consumables, Systems, Software), By Technology (CRISPER, TALEN, ZFN, Antisense), By Application (Cell Line Engineering, Genetic Engineering, Drug discovery), By End User (Pharma, Biotech, CROs), By Region and Competition, 2019-2029F”, has evaluated the future growth
potential of Global Gene Editing Market and provides
statistics & information on Market size, structure and future Market
growth. The report intends to provide cutting-edge Market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Gene Editing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com